NAA25-WSCD2 Fusion FISH Probe
The NAA25-WSCD2 Fusion FISH Probe is used to confirm a fusion of the NAA25 and WSCD2 genes. The fusion of the NAA25 and WSCD2 genes has been associated with Prostate Adenocarcinoma. These probes are FISH confirmed on normal peripheral blood in both interphase nuclei and metaphase spreads before shipment. Typical turnaround time for this product is 7-14 days after purchase.
** This product is for in vitro and research use only. This product is not intended for diagnostic use. Please note that both genes fall on the same chromosome and inter-chromosomal detection may be difficult to detect depending on the genes proximity to one another. Please consult our support staff before ordering this product to ensure that the probe can be designed to meet your specific needs.
| SKU | Test Kits | Buffer | Dye Color | Order Now |
|---|---|---|---|---|
| NAA25-WSCD2-20-ORGR (Standard Design) | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-RERE | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-REOR | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-REGO | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-REGR | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-REAQ | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-ORRE | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-OROR | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-ORGO | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-ORAQ | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-GORE | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-GOOR | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-GOGO | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-GOGR | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-GOAQ | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-GRRE | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-GROR | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-GRGO | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-GRGR | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-GRAQ | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-AQRE | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-AQOR | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-AQGO | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-AQGR | 20 (40 μL) | 200 μL |
|
|
| NAA25-WSCD2-20-AQAQ | 20 (40 μL) | 200 μL |
|
WSCD2 Gene Summary
The WSC Domain Containing 2 (WSCD2) gene is located on chr12 :108523510-108644313 at 12q23.3.
Gene Name: WSC Domain Containing 2
Chromosome: CHR12: 108523510 -108644313
Locus: 12q23.3
NAA25 Gene Summary
This gene encodes the auxiliary subunit of the heteromeric N-terminal acetyltransferase B complex. This complex acetylates methionine residues that are followed by acidic or asparagine residues.[provided by RefSeq, Mar 2010]
Gene Name: N(alpha)-acetyltransferase 25, NatB Auxiliary Subunit
Chromosome: CHR12: 112464492 -112546635
Locus: 12q24.13
Gene Diseases
The NAA25 WSCD2 Fusion has been associated with the following diseases:
| Disease Name |
|---|
| Prostate Adenocarcinoma |
FISH Probe Protocols
| Protocol, Procedure, or Form Name | Last Modified | Download |
|---|